Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A18327 | 27207512 | Diabetes | Variants in Genes Controlling Oxidative Metabolism Contribute to Lower Hepatic ATP Independent of Liver Fat Content in Type 1 Diabetes. | 2016 | Details |
| A18337 | 27197688 | J Diabetes Complications | Polyol accumulation in muscle and liver in a mouse model of type 2 diabetes. | 2016 | Details |
| A18341 | 27196572 | Gut | Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism. | 2016 | Details |
| A18347 | 27189281 | Yonsei Med J | The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter. | 2016 | Details |
| A18361 | 27182043 | J Diabetes Investig | Increased visceral adiposity with normal weight is associated with the prevalence of non-alcoholic fatty liver disease in Japanese patients with type 2 diabetes. | 2015 | Details |
| A18362 | 27181889 | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | [Roles of MicroRNA-21 in the Pathogenesis of Insulin Resistance and Diabetic Mellitus-induced Non-alcoholic Fatty Liver Disease]. | 2016 | Details |
| A18378 | 27173514 | Environ Int | Association between exposures to brominated trihalomethanes, hepatic injury and type II diabetes mellitus. | 2016 | Details |
| A18397 | 27161518 | J Diabetes Complications | Urine uric acid excretion is associated with nonalcoholic fatty liver disease in patients with type 2 diabetes. | 2016 | Details |
| A18409 | 27152734 | Curr Opin Clin Nutr Metab Care | Sugar and metabolic health: is there still a debate? | 2016 | Details |
| A18420 | 27146015 | Annu Rev Nutr | Citrus Flavonoids as Regulators of Lipoprotein Metabolism and Atherosclerosis. | 2016 | Details |
| A18421 | 27146014 | Annu Rev Nutr | Hormonal and Metabolite Regulation of Hepatic Glucokinase. | 2016 | Details |
| A18422 | 27146012 | Annu Rev Nutr | Alterations of Mitochondrial Function and Insulin Sensitivity in Human Obesity and Diabetes Mellitus. | 2016 | Details |
| A18429 | 27142870 | Diabetes Metab | Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: Causal association or epiphenomenon? | 2016 | Details |
| A18445 | 29182821 | Rinsho Byori | [Present State of Non-B Non-C Liver Disease-and Its Monitoring.] | 2016 | Details |
| A18447 | 28891620 | Zhongguo Zhong Yao Za Zhi | [Experimental study of Tangshen formulain improved lipid metabolism and phenotypic switch of macrophage in db/db mice]. | 2016 | Details |
| A18456 | 27123461 | J Diabetes Res | The Burden of NAFLD and Its Characteristics in a Nationwide Population with Type 2 Diabetes. | 2016 | Details |
| A18457 | 27122660 | World J Gastroenterol | Nonalcoholic fatty liver disease as a multi-systemic disease. | 2016 | Details |
| A18464 | 27110380 | BMJ Open Gastroenterol | Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease. | 2016 | Details |
| A18472 | 27106721 | Diabetologia | Higher body fat percentage is associated with enhanced temperature perception in NAFLD: results from the randomised Wessex Evaluation of fatty Liver and Cardiovascular markers in NAFLD with OMacor thErapy trial (WELCOME) trial. | 2016 | Details |
| A18477 | 27104526 | Int J Mol Sci | NAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms? | 2016 | Details |
| A18484 | 27101131 | Diabetologia | Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directions. | 2016 | Details |
| A18506 | 27085785 | Metabolism | Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. | 2015 | Details |
| A18507 | 27085779 | Metabolism | Computerized tomography measured liver fat is associated with low levels of N-terminal pro-brain natriuretic protein (NT-proBNP). Multi-Ethnic Study of Atherosclerosis. | 2016 | Details |
| A18521 | 27074921 | Dig Dis Sci | Treatment with Oxidized Phospholipids Directly Inhibits Nonalcoholic Steatohepatitis and Liver Fibrosis Without Affecting Steatosis. | 2016 | Details |
| A18528 | 27068982 | Biochem Soc Trans | Blood triacylglycerols: a lipidomic window on diet and disease. | 2016 | Details |
| A18537 | 27063276 | Clin Liver Dis | Extrahepatic Complications of Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18546 | 27063267 | Clin Liver Dis | Nonalcoholic Fatty Liver Disease: Lipids and Insulin Resistance. | 2016 | Details |
| A18554 | 28702244 | Clin Diabetes Endocrinol | Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with Type 2 Diabetes Mellitus. | 2016 | Details |
| A18577 | 27051590 | BBA Clin | Diabetic and dyslipidaemic morbidly obese exhibit more liver alterations compared with healthy morbidly obese. | 2016 | Details |
| A18579 | 27049380 | Int J Mol Sci | Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver Transplant. | 2016 | Details |
| A18591 | 27043550 | Int J Mol Sci | Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet. | 2016 | Details |
| A18594 | 27042272 | J Diabetes Investig | New risk-scoring system including non-alcoholic fatty liver disease for predicting incident type 2 diabetes in East China: Shanghai Baosteel Cohort. | 2015 | Details |
| A18600 | 27040341 | Yakugaku Zasshi | [Incretin as a Novel Treatment Strategy for NAFLD/NASH]. | 2016 | Details |
| A18604 | 27038703 | Dig Liver Dis | Non-alcoholic steatohepatitis and liver transplantation. | 2016 | Details |
| A18641 | 27019073 | Eur J Clin Invest | Sfrp5 associates with beta-cell function in humans. | 2016 | Details |
| A18643 | 27018279 | Geriatr Gerontol Int | Involvement of senescence marker protein-30 in glucose metabolism disorder and non-alcoholic fatty liver disease. | 2016 | Details |
| A18645 | 27017224 | Dig Dis Sci | Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016. | 2016 | Details |
| A18646 | 27017065 | Rev Mal Respir | [Obstructive sleep apnea syndrome: Metabolic complications]. | 2016 | Details |
| A18650 | 27015215 | Medicine (Baltimore) | The Application of Liver Stiffness Measurement in Residents Without Overt Liver Diseases Through a Community-Based Screening Program. | 2016 | Details |
| A18664 | 27005620 | Int J Mol Sci | Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight. | 2016 | Details |
| A18675 | 27002796 | Am J Gastroenterol | Gestational Diabetes Mellitus Is Strongly Associated With Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
| A18695 | 26997000 | Clin Cardiol | Fatty Liver, Insulin Resistance, and Obesity: Relationships With Increase in Coronary Artery Calcium Over Time. | 2016 | Details |
| A18699 | 26993825 | Dig Dis Sci | Significant Association Between Gallstone Disease and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. | 2016 | Details |
| A18707 | 26989059 | Obes Surg | Prevalence of Liver Fibrosis and its Association with Non-invasive Fibrosis and Metabolic Markers in Morbidly Obese Patients with Vitamin D Deficiency. | 2016 | Details |
| A18711 | 26985230 | Iran J Nurs Midwifery Res | The effect of vitamin D supplementation on blood sugar and different indices of insulin resistance in patients with non-alcoholic fatty liver disease (NAFLD). | 2016 | Details |
| A18720 | 26983473 | Zhonghua Gan Zang Bing Za Zhi | [Studies on association between nonalcoholic fatty liver disease and hyperuricemia: current status and future prospects]. | 2016 | Details |
| A18722 | 26983471 | Zhonghua Gan Zang Bing Za Zhi | [Advances in diagnosis and treatment of nonalcoholic fatty liver disease]. | 2016 | Details |
| A18736 | 26977813 | PLoS One | Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction. | 2016 | Details |
| A18738 | 26977755 | Am J Gastroenterol | Non-Alcoholic Fatty Liver Disease in Early Pregnancy Predicts Dysglycemia in Mid-Pregnancy: Prospective Study. | 2016 | Details |
| A18741 | 26976710 | Endocrinol Nutr | Effect of incretin therapies compared to pioglitazone and gliclazide in non-alcoholic fatty liver disease in diabetic patients not controlled on metformin alone: An observational, pilot study. | 2016 | Details |
| A18744 | 26975539 | Metabolism | Plasma osteoprotegerin levels are inversely associated with nonalcoholic fatty liver disease in patients with type 2 diabetes: A case-control study in China. | 2015 | Details |
| A18754 | 26970319 | Pediatr Diabetes | A cross-sectional view of the current state of treatment of youth with type 2 diabetes in the USA: enrollment data from the Pediatric Diabetes Consortium Type 2 Diabetes Registry. | 2016 | Details |
| A18757 | 26968296 | J Pak Med Assoc | Endocrine and metabolic effects of Glucagon like peptide 1 receptor agonists (GLP1RA). | 2016 | Details |
| A18767 | 26959059 | Nutrients | The Potential Protective Action of Vitamin D in Hepatic Insulin Resistance and Pancreatic Islet Dysfunction in Type 2 Diabetes Mellitus. | 2016 | Details |
| A18784 | 26944023 | Contemp Clin Trials | Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design. | 2016 | Details |
| A18802 | 26932748 | Sci Rep | Involvement of splenic iron accumulation in the development of nonalcoholic steatohepatitis in Tsumura Suzuki Obese Diabetes mice. | 2016 | Details |
| A18822 | 26921078 | Dig Dis Sci | Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD. | 2016 | Details |
| A18826 | 26916498 | Australas J Dermatol | Psoriasis and the liver: problems, causes and course. | 2016 | Details |
| A18829 | 26914659 | Clin Drug Investig | Effectiveness of Ipragliflozin, a Sodium-Glucose Co-transporter 2 Inhibitor, as a Second-line Treatment for Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus Who Do Not Respond to Incretin-Based Therapies Including Glucagon-like Peptide-1 Analogs and Dipeptidyl Peptidase-4 Inhibitors. | 2016 | Details |
| A18843 | 26907206 | Metabolism | Nonalcoholic fatty liver disease and hepatocellular carcinoma. | 2016 | Details |
| A18849 | 26905192 | Tissue Cell | The role of curcumin in streptozotocin-induced hepatic damage and the trans-differentiation of hepatic stellate cells. | 2016 | Details |
| A18859 | 26896612 | Environ Toxicol Pharmacol | High glucose regulates LN expression in human liver sinusoidal endothelial cells through ROS/integrin αvβ3 pathway. | 2016 | Details |
| A18873 | 26891869 | Biochem Biophys Res Commun | The molecular mechanisms between metabolic syndrome and breast cancer. | 2016 | Details |
| A18875 | 26890135 | Cell Death Dis | Caspase-2 promotes obesity, the metabolic syndrome and nonalcoholic fatty liver disease. | 2016 | Details |
| A18883 | 26887796 | Minerva Gastroenterol Dietol | Liver hemodynamic patterns in nonalcoholic steatosis: Doppler ultrasonography and histological evaluation. | 2016 | Details |
| A18894 | 26881444 | Curr Pharm Des | Interrelationship Between Periapical Lesion and Systemic Metabolic Disorders. | 2016 | Details |
| A18902 | 26878782 | J Nutr Biochem | A nutritional nonalcoholic steatohepatitis minipig model. | 2015 | Details |
| A18917 | 26871288 | Oncotarget | Sodium alginate prevents progression of non-alcoholic steatohepatitis and liver carcinogenesis in obese and diabetic mice. | 2016 | Details |
| A18918 | 26870973 | Georgian Med News | [ADIPONECTIN AND A VIOLATION OF METABOLIC CONTROL AT DIFFERENT STAGES OF NONALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES]. | 2016 | Details |
| A18923 | 26869052 | BMC Cardiovasc Disord | Non alcoholic fatty liver disease increases the mortality from acute coronary syndrome: an observational study from Sri Lanka. | 2016 | Details |
| A18932 | 26861926 | Diabetes Care | Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes. | 2016 | Details |
| A18942 | 26858016 | Liver Int | Impact of obesity and diabetes on waitlist survival, probability of liver transplantation and post-transplant survival among chronic hepatitis C virus patients. | 2016 | Details |
| A18944 | 26856933 | Metabolism | Non-alcoholic fatty liver disease and diabetes. | 2016 | Details |
| A18982 | 26834493 | Clin Exp Gastroenterol | Untreated newly diagnosed essential hypertension is associated with nonalcoholic fatty liver disease in a population of a hypertensive center. | 2016 | Details |
| A18989 | 26830854 | Endocrinol Nutr | Baseline ALT levels as a marker of glycemic response to treatment with GLP-1 receptor agonists. | 2016 | Details |
| A18993 | 26827440 | Lik Sprava | [PATOGENETIC VALUE OF VIOLATIONS FROM GLUTATHIONE SYSTEM AT THE PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS ON A BACKGROUND OF DIABETES MELLITUS TYPE II]. | 2016 | Details |
| A19000 | 26825843 | Dig Dis Sci | Screening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis. | 2016 | Details |
| A19002 | 26825357 | Curr Opin Organ Transplant | Nonalcoholic fatty liver: optimizing pretransplant selection and posttransplant care to maximize survival. | 2016 | Details |
| A19025 | 26813367 | Zhonghua Yi Xue Za Zhi | [Clinical features of non-alcoholic fatty liver disease and its relationship with serum C-peptide levels in patients with latent autoimmune diabetes in adults]. | 2015 | Details |
| A19030 | 26812073 | J Hepatol | Type 2 diabetes and risk of hospital admission or death for chronic liver diseases. | 2016 | Details |
| A19034 | 26810159 | Diabetes Metab Syndr | Correlation between non-alcoholic fatty liver disease (NAFLD) and dyslipidemia in type 2 diabetes. | 2016 | Details |
| A19042 | 26807360 | Quant Imaging Med Surg | Liver fat content is negatively associated with atherosclerotic carotid plaque in type 2 diabetic patients. | 2015 | Details |
| A19044 | 26806650 | Hepatology | Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice. | 2016 | Details |
| A19050 | 26803355 | Diabetes Res Clin Pract | Circulating adiponectin levels in type 2 diabetes mellitus patients with or without non-alcoholic fatty liver disease: Results of a small, open-label, randomized controlled intervention trial in a subgroup receiving short-term exenatide. | 2016 | Details |
| A19066 | 26786607 | Sao Paulo Med J | Influence of type 2 diabetes mellitus on liver histology among morbidly obese individuals. A cross-sectional study. | 2016 | Details |
| A19074 | 26783443 | Clin Case Rep | Insulin detemir may be less efficacious in patients with nonalcoholic fatty liver disease and hypertriglyceridemia. | 2015 | Details |
| A19079 | 26775764 | Nat Rev Endocrinol | The Framingham Heart Study--67 years of discovery in metabolic disease. | 2016 | Details |
| A19091 | 26770987 | J Diabetes Res | Nutrition and Physical Activity in Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19104 | 26763865 | Hepatol Res | Characteristics of non-obese non-alcoholic fatty liver disease: Effect of genetic and environmental factors. | 2016 | Details |
| A19107 | 26761949 | J Clin Res Pediatr Endocrinol | Sex Hormone-Binding Globulin in Children and Adolescents. | 2015 | Details |
| A19113 | 26755885 | World J Gastroenterol | Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents. | 2016 | Details |
| A19114 | 26755867 | World J Gastroenterol | Association between hepatitis B and metabolic syndrome: Current state of the art. | 2016 | Details |
| A19115 | 26755815 | J Investig Med | Plasma thyroid hormone concentration is associated with hepatic triglyceride content in patients with type 2 diabetes. | 2015 | Details |
| A19140 | 26732004 | Clin Lab | The Higher Prevalence of Non-Alcoholic versus Alcoholic Steatohepatitis in Alcoholics. | 2015 | Details |
| A19142 | 26731267 | PLoS One | The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice. | 2016 | Details |
| A19145 | 26728692 | J Intern Med | Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia. | 2016 | Details |
| A19146 | 26728273 | BMB Rep | The role of lipids in the pathogenesis and treatment of type 2 diabetes and associated co-morbidities. | 2016 | Details |
| A19168 | 30280846 | Eksp Klin Gastroenterol | [THE USE OF REMAXOL IN THE TREATMENT OF METABOLIC SYNDROME IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AND DIABETES MELLITUS 2 TYPE]. | 2018 | Details |
| A19176 | 29889442 | Eksp Klin Gastroenterol | THE ROLE OF BILE ACIDS IN THE REGULATION OF LIPID AND CARBOHYDRATE METABOLISM IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE AND DIABETES TYPE2. | 2018 | Details |
| A19180 | 29537209 | Pomeranian J Life Sci | Metabolic risk factors of coronary heart disease in relation to anthropometric measures in nonalcoholic fatty liver disease patients following dietary intervention. | 2018 | Details |